gold has been researched along with Leiomyosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badeka, A; Charalabopoulos, K; Georgiou, E; Hadjikakou, SK; Karkabounas, S; Kourkoumelis, N; Metsios, A | 1 |
| Albertini, M; Gan, J; Hank, J; Heisey, D; Larson, M; Mahvi, DM; Pharo, L; Schalch, H; Schiller, J; Shi, FS; Sondel, PM; Warner, T; Weber, S; Yang, NS | 1 |
1 trial(s) available for gold and Leiomyosarcoma
| Article | Year |
|---|---|
Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: report of a phase I/IB study.
Topics: Biolistics; Cancer Vaccines; DNA, Complementary; Dose-Response Relationship, Immunologic; Feasibility Studies; Gold; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypersensitivity, Delayed; Immunologic Factors; Injections, Intradermal; Leiomyosarcoma; Liposarcoma; Melanoma; Safety; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Vaccines, DNA | 2002 |
1 other study(ies) available for gold and Leiomyosarcoma
| Article | Year |
|---|---|
Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Computational Biology; Drug Screening Assays, Antitumor; Gold; Leiomyosarcoma; Ligands; Lipoxygenase; Models, Molecular; Molecular Structure; Organogold Compounds; Organophosphorus Compounds; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship; Thioamides | 2011 |